Can Ivermectin Help in Cancer Current Research, Evidence & Safety

Ivermectin 12mg is widely known as an antiparasitic medication used to treat infections caused by parasites such as roundworms and lice. Recently, research has emerged investigating its potential use in cancer treatment. Laboratory studies have suggested that Ivermectin may have properties that could inhibit cancer cell growth or induce cancer cell death in certain types of cancer. However, it is important to stress that these findings are preliminary and mostly limited to laboratory or animal studies. Currently, there is no strong clinical evidence supporting the use of Ivermectin 12mg as a cancer treatment in humans. Ongoing research aims to better understand its mechanisms and potential benefits. Patients should not use Ivermectin for cancer outside of clinical trials or without medical supervision. When considering any medication, safety is crucial. Ivermectin is generally well tolerated when used as prescribed for parasitic infections, but side effects can occur. Common side effects include dizziness, nausea, diarrhea, and skin rash. Serious reactions are rare but possible. It is essential to consult a qualified healthcare professional before starting, stopping, or changing any medication. They can provide guidance based on the most current research and your individual health needs. In summary, while Ivermectin 12mg shows promise in early cancer research, more studies are needed to confirm its effectiveness and safety for this purpose. Patients should rely on proven cancer treatments and professional medical advice.